期刊文献+

A型肉毒杆菌毒素水凝胶去神经支配作用的定量研究 被引量:3

QUALITATIVE ANALYSIS ON THE DENERVATING ACTION OF BOTULINUM TOXIN A IN GEL
下载PDF
导出
摘要 目的:探讨改变剂型后的A型肉毒杆菌毒素(BTXA)的生物活性是否存在,并对其去神经支配作用进行定量分析。方法:SD大鼠36只,随机分成4组。A^D组随机一侧腓肠肌肌内注射BTXA水溶液0.1 ml(5U)、BTX-A水凝胶0.1 ml(12.5U)、0.1 ml(5U)及0.1 ml(2U),对侧腓肠肌肌内注射0.1 ml相应溶剂。于用药前、用药后5d、2周、3周、1个月、2个月及3个月分别测定双侧腓肠肌复合动作电位(CMAP),并记录波幅。结果:不同时间段用药侧与对侧腓肠肌CMAP波幅的下降幅度比较有非常显著性差异(P<0.01),用药后的用药侧与对侧腓肠肌CMAP波幅的下降幅度均明显高于用药前(P<0.01);各组间的用药侧与对侧CMAP波幅的下降幅度比较有非常显著性差异(P<0.01),A组及B组的下降幅度明显高于C组及D组(P<0.01),A组及B组比较则没有显著性差异,C组的下降幅度高于D组(P<0.01)。结论:水凝胶剂型的BTXA不仅保存了其去神经支配的生物活性,且表现明显的量效关系和时效关系。 Aim: To ascertain the bioactivity and to analyse quantificationally the denervating action of botulinum toxin A (BTXA) in gel. Methods: 36 Spragne-Dawley rats were randomized into four groups. In group A--D, the gastroenemius muscle of one leg was randomly selected to receive injection of BTXA solution 5U in 0.1 ml, BTXA gel 12 .SU in 0.1 ml, BTXA gel 5U in 0.1 ml and BTXA gel 2U in 0.1 ml respectively, while the gastrocnemius muscle of other leg was injected with 0.1 ml of saline solution in group A and 0.1 ml of gel in group B to group D as control. Compound muscle action potential (CMAP) of both gastrocnemius muscles were measured and the amplitudes were recorded before injections, and 5 days, 2 weeks, 3 weeks, 1 month, 2 months and 3 months after the injections respectively. Results: The reduction of CMAP amplitude was significantly different at various time( P 〈 0.01 ), and CMAP amplitude decreased significantly after the treatment of BTXA(P〈0.01). The reduction of CMAP amplitude was significantly dif- ferent in group A to D(P〈0.01),and more reduction was found in group A and B(P〈0.01), and the reduction was higher in group C than in group D(P 〈 0.05). However, there were no significant differences in the reduction of CMAP amplitude between group A and group B. Conclusion: Bioactivity of BTXA in gel was showed and the denervating action of BTXA in gel was demonstrated in a dosage and time dependent manner.
出处 《中国应用生理学杂志》 CAS CSCD 北大核心 2008年第1期104-107,共4页 Chinese Journal of Applied Physiology
关键词 肉毒杆菌毒素 水凝胶 生物活性 去神经支配 复合肌肉动作电位 botulinurn toxin gel bioactivity denervating action compound muscle action potential
  • 相关文献

参考文献1

二级参考文献8

  • 1Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology, 1980 ; 87: 1044-1049.
  • 2Munchau A, Bhatia K P. Uses of botulinum toxin injection in medicine today. BMJ, 2000; 320: 161-165.
  • 3Burns CL, Gammon JA, Gemmill MC.Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm. Ophthalmology, 1986; 93 : 1621- 1627.
  • 4Quah BL, Ling YL, Cheong PY, et al. A review of 5 years' experience in the use of botulinium toxin A in the treatment of sixth cranial nerve palsy at the Singapore National Eye Centre, Singapore Med J,1999 ; 40 : 405-409.
  • 5Joseph KC, Tsu I. Botulinum toxin as a therapeutic agent. Pharmacol Ther, 1996;72( 1 ) : 13-24.
  • 6Eleopra R, Tugnoli V, Caniatti L, et al. Botulinum toxin treatment in the faeial museles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology, 1996; 46.1158-1160.
  • 7Camber O, Edman P. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine. Curr Eye Res, 1989; 563-567.
  • 8Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol, 1991 ; 36:28-46.

共引文献1

同被引文献28

  • 1王国栋,赵永波.不同稀释度A型肉毒毒素治疗偏侧面肌痉挛的疗效观察[J].中国全科医学,2009,12(15):1428-1429. 被引量:10
  • 2罗蔚锋,刘春风,包仕尧,戴永萍,赵合庆.不同稀释度A型肉毒毒素治疗痉挛性斜颈的疗效观察[J].临床神经病学杂志,2004,17(6):463-464. 被引量:8
  • 3陈静嫦,麦光焕,余新平,余焕云,吴河坪.兔眼内直肌注射肉毒杆菌毒素水凝胶的药物分布[J].眼科新进展,2007,27(3):193-195. 被引量:2
  • 4Schulte-Mattler WJ. Use of botulinum toxin A in adult neurolog-ical disorders:efficacy,tolerability and safety[J]. CNS Drugs,2008,22(9):725-738.
  • 5de Sa EA,Marmur ES. The five D"s of botulinum toxin:doses,dilution,diffusion,duration and dogma[J]. J Cosmet Laser Ther,2008,10(2):93-102.
  • 6Grades JM,Lugassy M,Weisz DJ,et al. Botulinum toxin dilu-tion and endplate targeting in spasticity:a double-blind con-trolled study [J]. Arch Phys Med Rehabil,2009,90(1):9-16.
  • 7Lee JH,Sung IY,Yoo JY,et al. Effects of different dilutions ofbotulinum toxin type A treatment for children with cerebral pal-sy with spastic ankle plantarflexor:a randomized controlled trial[J]. J Rehabil Med,2009,41(9):740-745.
  • 8Aoki KR. A comparison of the safety margins of botulinum neu-rotoxin serotypes A,B,and F in mice[J]. Toxicon,2001,39(12):1815-1820.
  • 9Wortzman MS,Pickett A. The science and manufacturing be-hind botulinum neurotoxin type A-ABO in clinical use[J]. Aes-thet Surg J,2009,29(6 Suppl):S34-S42.
  • 10Lucioni A,Bales GT,Lotan TL,et al. Botulinum toxin type A in-hibits sensory neuropeptide release in rat bladder models ofacute injury and chronic inflammation[J]. BJU Int,2008,101(3):366-370.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部